Protocol No
ALLIANCE-A041703-ALL
Phase
II
Summary
We are doing this study because we want to find out if this approach is better or worse than the usual approach for acute lymphoblastic leukemia. The usual approach is defined as: care most people get for acute lymphoblastic leukemia.
Description
Inotuzumab Ozogamicin & Blinatumomab in Patients w/ Newly Diagnosed, Recurrent, or Refractory ALL
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov